Please use this identifier to cite or link to this item: https://hdl.handle.net/1/2718
Full metadata record
DC FieldValueLanguage
dc.contributor.authorIrwin, Matthew P-
dc.contributor.authorDutta, Trisha-
dc.contributor.authorJambor, Maxwell-
dc.contributor.authorMorgan, Matthew J-
dc.contributor.authorTurner, Catherine E-
dc.contributor.authorLiang, Yicong-
dc.date.accessioned2024-09-05T03:14:14Z-
dc.date.available2024-09-05T03:14:14Z-
dc.date.issued2024-07-
dc.identifier.citation94(7-8):1273-1278en
dc.identifier.urihttps://hdl.handle.net/1/2718-
dc.description.abstractColorectal cancer is the second most common cause of cancer mortality in Australia (1). The National Bowel Cancer Screening Program (NBCSP) aims to reduce mortality through early detection with a biennial faecal occult blood test for Australians aged 50-74 years (2). Modelling predicted COVID-19 would reduce participation and delay colonoscopies despite the NBCSP continuing during the pandemic (3). This study analyses the realized impact of COVID-19 related disruptions on the NBCSP and the effect on mortality. NBCSP participation, time to colonoscopy and annualized mortality were compared before and during COVID-19. The effect on mortality was determined using a validated microsimulation model (4, 5). From 1 January 2018 to 31 December 2019, 2 497 317 people participated in the NBCSP and 168 390 received a colonoscopy, compared to 2 490 265 and 162 573 from 1 January 2020 to 31 December 2021. Relative participation decreased 6 % and the proportion of colonoscopies performed within the recommended 120 days increased 14.5%. A disproportionally greater impact was observed outside major cities and in lower socioeconomic areas. An estimated 98-111 additional colorectal cancer deaths resulted from 3 % fewer colonoscopies performed during the pandemic. This study presents the most comprehensive analysis of the realized impact of COVID-19 on the NBCSP. Catch-up screening would be best targeted at Australians from rural and lower socioeconomic areas where participation remains low. Streamlined referral pathways and additional colonoscopy provisioning is required as less than two thirds of screen positive patients receive a colonoscopy within the recommended 120 days.en
dc.description.sponsorshipGeneral Surgeryen
dc.subjectGastrointestinal Tracten
dc.titleRealized impact of COVID-19 related disruptions on the National Bowel Cancer Screening Programen
dc.typeJournal Articleen
dc.identifier.doi10.1111/ans.18894en
dc.description.pubmedurihttps://pubmed.ncbi.nlm.nih.gov/38345127en
dc.description.affiliatesCentral Coast Local Health Districten
dc.description.affiliatesWyong Hospitalen
dc.identifier.journaltitleANZ Journal of Surgeryen
dc.type.contentTexten
item.fulltextNo Fulltext-
item.openairetypeJournal Article-
item.grantfulltextnone-
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
Appears in Collections:Health Service Research
Show simple item record

Page view(s)

10
checked on Oct 3, 2024

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.